|Articles|September 9, 2021
Positioning Biobanking Assets for Maximum Value
Author(s)Crosstree
As precision medicine grows, so, too, does demand for biobanking services, offering both strategic and financial investors a significant opportunity for value creation.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
What Impact Could Recent US Regulatory Actions Have on Global Pricing and Launches?
2
Why Ireland Has Become a Strategic Hub for the Global Pharmaceutical Industry
3
Pharma M&A Roundup: IMG Pharma Acquires Matsumoto Pharmaceutical, Sun Pharma Acquires Organon
4
FDA Approves Breztri for Patients 12 Years and Older with Asthma
5